Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KMDA |
---|---|---|
09:32 ET | 455 | 5.8301 |
09:37 ET | 2913 | 5.87 |
10:09 ET | 1000 | 5.86 |
10:11 ET | 200 | 5.88 |
10:15 ET | 100 | 5.88 |
10:20 ET | 1500 | 5.88 |
10:24 ET | 700 | 5.89 |
10:27 ET | 400 | 5.8993 |
10:33 ET | 1000 | 5.89 |
10:40 ET | 300 | 5.89 |
10:42 ET | 274 | 5.89 |
10:49 ET | 200 | 5.89 |
11:00 ET | 100 | 5.89 |
11:16 ET | 2300 | 5.89 |
11:21 ET | 292 | 5.88 |
11:39 ET | 500 | 5.8802 |
11:45 ET | 100 | 5.89 |
12:01 ET | 300 | 5.88 |
12:10 ET | 300 | 5.89 |
12:21 ET | 324 | 5.895 |
12:26 ET | 739 | 5.895 |
12:48 ET | 300 | 5.9 |
12:51 ET | 808 | 5.89 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kamada Ltd | 334.0M | 19.0x | -22.48% |
Sutro Biopharma Inc | 221.8M | -1.6x | --- |
Karyopharm Therapeutics Inc | 109.8M | -1.1x | --- |
Heron Therapeutics Inc | 176.4M | -6.5x | --- |
Seres Therapeutics Inc | 149.7M | -0.9x | --- |
Arcturus Therapeutics Holdings Inc | 474.3M | -7.9x | --- |
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $334.0M |
---|---|
Revenue (TTM) | $158.4M |
Shares Outstanding | 57.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.99 |
EPS | $0.31 |
Book Value | $4.25 |
P/E Ratio | 19.0x |
Price/Sales (TTM) | 2.1 |
Price/Cash Flow (TTM) | 11.7x |
Operating Margin | 11.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.